Live attenuated vaccine against Aujeszky’s disease, lyophilisate and solvent for solution for injection
The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.
*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..
Quick product information
Active ingredient(s) | Posology* | Waiting time | Packaging |
---|---|---|---|
Live attenuated Aujeszky’s disease virus, Bartha strain K61 gE- | Intramuscular injection or intranasal administration | Zero days | 10 doses (1×10) 50 doses (1×50) 100 doses (1×100 or 2×50) 200 doses (20×10) 500 doses (10×50) 1,000 doses (20×50 or 10×100) |
Country Availability
Russia, Spain, Vietnam.
If your country is not listed, please contact our export team.
Active ingredient(s)
Lyophilisate: Aujeszky’s Disease Virus, Bartha strain K61 gE-…………………………………………………….≥10 6 TCID050
Aqueous diluent ……………………………………………………………………………………………..2 ml.
Indications
For the active immunisation of Aujeszky’s disease in pigs to prevent infection and reduce mortality, clinical signs and/or lesions of the disease.
Onset of immunity: 3 weeks after revaccination.
Posology
2 ml/animal.
Vaccination based on the official eradication and control programme.
Waiting time
Zero days.
Packaging
Supply of 10 doses: Box with 1 vial of 10 doses of lyophilised vaccine and 1 vial with 20 ml of solvent.
Supply of 50 doses: Box with 1 vial of 50 doses of lyophilised vaccine and 1 vial with 100 ml of solvent.
Supply of 50 doses: Box with 1 vial of 50 doses of lyophilised vaccine and 1 vial with 100 ml of solvent.
Supply of 100 doses: Box with 1 vial of 100 doses of lyophilised vaccine and 1 glass vial with 200 ml of solvent.
Supply of 100 doses: Box with 1 vial of 100 doses of lyophilised vaccine and 1 polypropylene vial with 200 ml of solvent.
Supply of 100 doses: Box with 2 vials of 50 doses of lyophilised vaccine and 2 glass vials with 100 ml of solvent.
Supply of 100 doses: Box with 2 vials of 50 doses of lyophilised vaccine and 2 polypropylene vials with 100 ml of solvent.
Supply of 200 doses: Box with 20 vials of 10 doses of lyophilised vaccine and 20 vials with 20 ml of solvent.
Supply of 500 doses: Box with 10 vials of 50 doses of lyophilised vaccine and 10 vials with 100 ml of solvent.
Supply of 500 doses: Box with 10 vials of 50 doses of lyophilised vaccine and 10 polypropylene vials with 100 ml of solvent.
Supply of 1,000 doses: Box with 20 vials of 50 doses of lyophilised vaccine and 2 boxes with 10 glass vials with 100 ml of solvent in each.
Supply of 1,000 doses: Box with 20 vials of 50 doses of lyophilised vaccine and 2 boxes with 10 polypropylene vials with 100 ml of solvent in each.
Supply of 1,000 doses: Box with 10 vials of 100 doses of lyophilised vaccine and 10 vials with 200 ml of solvent.
Supply of 1,000 doses: Box with 10 vials of 100 doses of lyophilised vaccine and 10 polypropylene vials with 200 ml of solvent.
Not all forms of the drug may be marketed.
With veterinary prescription.
Registry no.: 2572 ESP